CCNE1 and BRD4 expression and platinum resistance in high-grade serous ovarian cancers

被引：0
|
作者：
Petersen, S. S. [1 ]
Wilson, A. J. [2 ]
Khabele, D. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[2] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2437
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [1] CCNE1 AND BRD4 EXPRESSION AND PLATINUM RESISTANCE IN HIGH-GRADE SEROUS OVARIAN CANCERS
    Petersen, Shariska
    Wilson, Andrew J.
    Khabele, Dineo
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 110 - 110
  • [2] CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
    Petersen, Shariska
    Wilson, Andrew J.
    Hirst, Jeff
    Roby, Katherine F.
    Fadare, Oluwole
    Crispens, Marta A.
    Beeghly-Fadiel, Alicia
    Khabele, Dineo
    GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 405 - 410
  • [3] Patterns of BRD4 protein expression in advanced stage high-grade serous ovarian cancers
    Petersen, S. S.
    Aliani, R.
    Amaya, S.
    Wilson, A. J.
    Khabele, D.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 150 - 150
  • [4] The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer
    Andrikopoulou, Angeliki
    Bletsa, Garyfalia
    Rouvalis, Angeliki
    Tsakogiannis, Dimitris
    Kaparelou, Maria
    Papatheodoridi, Alkistis
    Haidopoulos, Dimitrios
    Liontos, Michalis
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    CANCERS, 2024, 16 (11)
  • [5] CCNE1 amplification in high-grade serous ovarian cancer: analysis of the GENIE database
    Al-Akhras, Ashaar
    Tashtoush, Shaden
    Ghazou, Alina
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Protein expression by immunohistochemistry is associated with CCNE1 and BRD4 gene amplification
    Petersen, Shariska
    Golem, Shivani
    Shahiri, Parmida
    Wilson, Andrew
    Spoozak, Lori
    Jewell, Andrea
    Khabele, Dineo
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : E30 - E30
  • [7] BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer
    Rhyasen, Garrett W.
    Yao, Yi
    Dulak, Austin
    Castriotta, Lillian
    Jacques, Kelly
    Hattersley, Maureen
    Mills, Gordon B.
    Zinda, Michael
    Fawell, Stephen
    Lyne, Paul
    Clark, Edwin
    Chen, Huawei
    CANCER RESEARCH, 2016, 76
  • [8] CCNE1 is a potential target of Metformin for tumor suppression of ovarian high-grade serous carcinoma
    Mei, Jie
    Tian, Huixiang
    Huang, Hsuan-Shun
    Wu, Nayiyuan
    Liou, Yu-Ligh
    Chu, Tang-Yuan
    Wang, Jing
    Zhang, Wei
    CELL CYCLE, 2023, 22 (01) : 85 - 99
  • [9] The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
    Drumond-Bock, Ana Luiza
    Bieniasz, Magdalena
    MOLECULAR CANCER, 2021, 20 (01)
  • [10] The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
    Ana Luiza Drumond-Bock
    Magdalena Bieniasz
    Molecular Cancer, 20
12345